2,2-dichloro-3-(2,5-dimethoxyphenyl)-3-phenylcyclobutanone | 1381864-99-8

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 2,2-dichloro-3-(2,5-dimethoxyphenyl)-3-phenylcyclobutanone
• 英文别名: 2,2-Dichloro-3-(2,5-dimethoxyphenyl)-3-phenylcyclobutan-1-one
• CAS: 1381864-99-8
• 化学式: C₁₈H₁₆Cl₂O₃
• 分子量: 351.229
• InChiKey: NKDIUSORKUYBOY-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.3
• 重原子数：
  23
• 可旋转键数：
  4
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.28
• 拓扑面积：
  35.5
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  2,2-dichloro-3-(2,5-dimethoxyphenyl)-3-phenylcyclobutanone 在 三甲基铝 、 三溴化硼 、 溶剂黄146 、 肼 、 锌 作用下， 以 二氯甲烷 为溶剂， 生成 2-(1-phenylcyclopentyl)benzene-1,4-diol
  参考文献：
  名称：

  Evaluation of endo- and exo-aryl-substitutions and central scaffold modifications on diphenyl substituted alkanes as 5-lipoxygenase activating protein inhibitors

  摘要：

  A search for a suitable replacement for the central norbornyl scaffold presented in the recently disclosed novel FLAP inhibitors is herein described, as well as the SAR study performed on the endo and exo-aryl groups. (C) 2012 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2012.04.064
• 作为产物：
  描述：

  1-(2,5-dimethoxy-phenyl)-1-phenyl-ethanol 在 对甲苯磺酸 、 锌 作用下， 以 甲醇 、 乙醚 为溶剂， 生成 2,2-dichloro-3-(2,5-dimethoxyphenyl)-3-phenylcyclobutanone
  参考文献：
  名称：

  Evaluation of endo- and exo-aryl-substitutions and central scaffold modifications on diphenyl substituted alkanes as 5-lipoxygenase activating protein inhibitors

  摘要：

  A search for a suitable replacement for the central norbornyl scaffold presented in the recently disclosed novel FLAP inhibitors is herein described, as well as the SAR study performed on the endo and exo-aryl groups. (C) 2012 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2012.04.064

文献信息

• Diphenyl Substituted Cycloalkanes, Compositions Containing Such Compounds and Methods Of Use
  申请人：Armstrong Helen M.

  公开号：US20090197883A1

  公开（公告）日：2009-08-06

  The instant invention provides compounds of Formula (I) which are 5-lipoxygenase activating protein inhibitors. Compounds of Formula (I) are useful as anti-atherosclerotic, anti-asthmatic, anti-allergic, anti-inflammatory and cytoprotective agents.

  本发明提供了式（I）的化合物，它们是5-脂氧酶活化蛋白抑制剂。式（I）的化合物可用作抗动脉粥样硬化、抗哮喘、抗过敏、抗炎和细胞保护剂。
• WO2006/98912
  申请人：——

  公开号：——

  公开（公告）日：——
• Evaluation of endo- and exo-aryl-substitutions and central scaffold modifications on diphenyl substituted alkanes as 5-lipoxygenase activating protein inhibitors
  作者：Lin Chu、Helen M. Armstrong、Linda L. Chang、Amy F. Cheng、Lawrence Colwell、Jisong Cui、Jilly Evans、Amy Galka、Mark T. Goulet、Nancy Hayes、Jane Lo、John Menke、Hyun O. Ok、Debra L. Ondeyka、Minal Patel、Grace M. Quaker、Heather Sings、Stephanie L. Witkin、Annie Zhao、Feroze Ujjainwalla

  DOI：10.1016/j.bmcl.2012.04.064

  日期：2012.6

  A search for a suitable replacement for the central norbornyl scaffold presented in the recently disclosed novel FLAP inhibitors is herein described, as well as the SAR study performed on the endo and exo-aryl groups. (C) 2012 Elsevier Ltd. All rights reserved.